Articles by tag: wegovy

EMA recommended the first oral GLP-1 drug for weight loss | Wegovy

EMA issued a positive opinion on the first oral GLP-1 Wegovy for weight loss. Analysis of efficacy, price, side effects and market forecast. Read details.

EMA approved the first oral GLP-1 drug Wegovy for weight control

EMA recommended the first GLP-1 tablet for weight loss — Wegovy (semaglutide) 25 mg. Efficacy up to 16.6% weight loss. Market analysis, winners and losers. Learn more.